Jane Street’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$92.9M Buy
666,637
+606,009
+1,000% +$84.9M 0.01% 677
2025
Q4
$7.44M Sell
60,628
-823,844
-93% -$100M ﹤0.01% 2686
2025
Q3
$98.2M Buy
884,472
+634,948
+254% +$72.2M 0.01% 608
2025
Q2
$27.7M Sell
249,524
-621,075
-71% -$66.1M 0.01% 1155
2025
Q1
$97.6M Buy
870,599
+286,196
+49% +$29.5M 0.02% 386
2024
Q4
$54M Buy
584,403
+396,845
+212% +$35.7M 0.01% 662
2024
Q3
$15.7M Sell
187,558
-237,783
-56% -$18.1M ﹤0.01% 1446
2024
Q2
$29.2M Sell
425,341
-319,661
-43% -$21.3M 0.01% 1004
2024
Q1
$54.6M Buy
745,002
+445,861
+149% +$34.3M 0.01% 585
2023
Q4
$24.2M Buy
299,141
+108,443
+57% +$8.44M 0.01% 1113
2023
Q3
$14.3M Sell
190,698
-3,746
-2% -$288K ﹤0.01% 1407
2023
Q2
$15M Buy
194,444
+8,795
+5% +$701K 0.01% 1489
2023
Q1
$15.4M Sell
185,649
-559,654
-75% -$46.4M 0.01% 1211
2022
Q4
$64M Buy
745,303
+552,756
+287% +$43.8M 0.03% 429
2022
Q3
$11.9M Buy
192,547
+124,039
+181% +$7.82M 0.01% 1530
2022
Q2
$4.23M Sell
68,508
-504,359
-88% -$31.2M ﹤0.01% 2917
2022
Q1
$34.1M Buy
572,867
+323,845
+130% +$20.7M 0.01% 897
2021
Q4
$18.1M Buy
249,022
+81,864
+49% +$5.64M 0.01% 1296
2021
Q3
$11.7M Sell
167,158
-167,989
-50% -$11.8M ﹤0.01% 1613
2021
Q2
$23.1M Buy
335,147
+4,772
+1% +$319K 0.01% 976
2021
Q1
$21.4M Sell
330,375
-138,663
-30% -$8.94M 0.01% 921
2020
Q4
$27.3M Buy
469,038
+168,274
+56% +$10.2M 0.01% 696
2020
Q3
$19M Sell
300,764
-88,971
-23% -$6.17M 0.01% 804
2020
Q2
$30M Sell
389,735
-290,207
-43% -$22.2M 0.02% 548
2020
Q1
$50.8M Buy
679,942
+594,199
+693% +$41.1M 0.05% 242
2019
Q4
$5.57M Sell
85,743
-65,877
-43% -$4.29M 0.01% 992
2019
Q3
$9.61M Buy
151,620
+22,210
+17% +$1.45M 0.02% 621
2019
Q2
$8.74M Sell
129,410
-104,854
-45% -$6.9M 0.02% 704
2019
Q1
$15.2M Buy
234,264
+86,955
+59% +$5.78M 0.02% 513
2018
Q4
$9.21M Sell
147,309
-45,071
-23% -$3.15M 0.02% 618
2018
Q3
$14.9M Buy
192,380
+37,380
+24% +$2.82M 0.03% 426
2018
Q2
$11M Buy
155,000
+55,247
+55% +$3.9M 0.03% 564
2018
Q1
$7.52M Sell
99,753
-214,849
-68% -$17.1M 0.02% 694
2017
Q4
$22.5M Sell
314,602
-158,045
-33% -$12M 0.06% 271
2017
Q3
$38.3M Buy
472,647
+176,019
+59% +$13.5M 0.12% 158
2017
Q2
$21M Buy
296,628
+73,825
+33% +$4.91M 0.07% 233
2017
Q1
$15.1M Sell
222,803
-17,637
-7% -$1.24M 0.07% 256
2016
Q4
$17.2M Buy
240,440
+121,300
+102% +$9.02M 0.08% 210
2016
Q3
$9.43M Buy
119,140
+39,681
+50% +$3.22M 0.05% 330
2016
Q2
$6.63M Sell
79,459
-37,355
-32% -$3.32M 0.03% 501
2016
Q1
$10.7M Buy
116,814
+37,137
+47% +$3.35M 0.06% 283
2015
Q4
$8.06M Buy
79,677
+69,105
+654% +$7.19M 0.05% 336
2015
Q3
$1.04M Sell
10,572
-3,607
-25% -$401K 0.01% 1597
2015
Q2
$1.66M Sell
14,179
-1,810
-11% -$198K 0.01% 1131
2015
Q1
$1.57M Sell
15,989
-70,508
-82% -$7.16M 0.01% 1039
2014
Q4
$8.15M Sell
86,497
-199,608
-70% -$20.6M 0.06% 229
2014
Q3
$30.5M Buy
286,105
+221,176
+341% +$21.7M 0.31% 56
2014
Q2
$5.38M Buy
64,929
+58,475
+906% +$4.55M 0.07% 243
2014
Q1
$457K Sell
6,454
-15,503
-71% -$1.22M 0.01% 1652
2013
Q4
$1.65M Sell
21,957
-81,531
-79% -$5.68M 0.02% 553
2013
Q3
$6.51M Buy
103,488
+29,417
+40% +$1.76M 0.08% 192
2013
Q2
$3.8M Buy
+74,071
New +$3.86M 0.07% 227

Other funds holding GILD

Jane Street's GILD Position: Q1 2026 in Review

Jane Street increased its Gilead Sciences (GILD) stake by 1,000% in Q1 2026, buying an estimated $84.9M and bringing the position to 666,637 shares worth $92.9M. The position accounts for 0.01% of the portfolio, ranked #677.

Jane Street first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $98.2M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Jane Street held 666,637 shares of Gilead Sciences worth $92.9M as of Q1 2026.
  • Jane Street bought 606,009 Gilead Sciences shares in Q1 2026, an estimated $84.9M.
  • Gilead Sciences made up 0.01% of Jane Street's portfolio in Q1 2026, its #677 holding.
  • Jane Street first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Jane Street's Gilead Sciences position peaked at $98.2M in Q3 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.